Teva Pharmaceuticals USA, Inc Recalls

2 recalls found for Teva Pharmaceuticals USA, Inc — spanning April 2026 through April 2026.

Medications: 2

The recalls listed below are all active notices associated with Teva Pharmaceuticals USA, Inc in the FDA, NHTSA, USDA, and CPSC databases. A recall notice may cover specific lot numbers, model numbers, or production date ranges — check each notice carefully to determine whether your specific product is affected.

If you own a recalled product, stop using it and follow the instructions in the official notice for a refund, replacement, or free repair. Vehicle recall repairs are always free regardless of warranty status. For food and consumer products, most retailers will accept returns even without a receipt.

NoticeMedications

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL

Teva Pharmaceuticals USA, Inc

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

View recall →
NoticeMedications

Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs

Teva Pharmaceuticals USA, Inc

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin